Caspase-3 and -7 represent executioner/effector caspases that directly cause apoptotic morphological changes by cleaving various death substrates. The substrates for caspases generally interact with active caspases, but not with inactive zymogens of caspase or procaspases. Here, to isolate proteins that interact with caspase-7, we established a yeast two-hybrid screening system using reversedcaspase-7, a constitutive active mutant of caspase-7 as a bait plasmid. Screening of an adult brain cDNA library led to isolation of proteasome activator 28 subunit, PA28g. In vitro translates of PA28g were cleaved by both recombinant caspase-3 and -7. Mutagenesis of potential cleavage site DGLD 80 to EGLE 80 completely abolished caspase-mediated cleavage. Moreover, endogenous PA28g was cleaved during not only Fas-induced apoptosis of HeLa cells, but also cisplatin-induced cell death of MCF7 cells, which are devoid of caspase-3. These findings indicate that PA28g is an endogenous substrate for caspase-3 and -7 and that yeast two-hybrid screening using reversed-caspase is a novel and useful approach to clone substrates for effector caspases.
Introduction
Apoptosis is an actively performed cellular suicidal process essential for the development and maintenance of tissue homeostasis of multi-cellular organisms. Apoptosis is characterized by prominent morphological features such as membrane blebbing, nuclear condensation, DNA fragmentation and apoptotic body formation. A family of cysteine proteases called caspases plays a critical role in the execution of apoptosis, from nematodes to humans. To date, 14 mammalian caspases have been identified. 1 Caspases are synthesized as inactive zymogens that become activated by cleavage after a specific aspartate residue within a linker domain between a large subunit (LS) and a small subunit (SS), in addition to cleaving off of the NH 2 -terminal prodomain. The LS and SS subsequently combine into a heterodimer to form active caspases. 2 When cells receive death signals, a subset of caspases are activated in an organized fashion and lead to processing and activation of crucial effector/executioner caspases.
Effector caspases, represented by caspase-3, -6 and -7, specifically cleave cellular proteins or`death substrates', and govern the changes characterizing apoptotic morphology. Thus, death substrates play an important role in determining the final apoptotic phenotype. Caspase-dependent cleavage inactivates a subgroup of substrates such as PARP, nuclear lamin, Bcl-2 and b-catenin, whereas activates a different subgroup of substrates including MEKK1, p21-activated kinase, protein kinase Cd and the ICAD/CAD complex. 3 Although the role of death substrate cleavage in the apoptotic phenotype is partially understood, the substrates essential for causing cell death remain unknown.
Caspases-3 and -7 are closely related caspases in sequence similarity as well as in substrate specificity. 4, 5 Recombinant large or small subunit of caspase-7 can form active heteromeric complexes with the caspase-3 counterpart. 4 Both caspases show overlapping substrate specificities with special preference for the DEVD motif. However, these highly related caspases are differentially regulated in subcellular localization during apoptosis, suggesting the presence of caspase-3 or -7 specific substrates. 6 The role of caspase-7 is still ill-defined, unlike caspase-3 which has been shown to play a central role in apoptosis execution. Thus, we attempted to clone new substrates for caspase-7.
ing, resulting in the cloning of 20S proteasome activator 28 subunit 3, PA28g. Subsequent studies showed that PA28g is cleaved by caspase-3 or -7 both in vitro and in vivo, indicating that PA28g is a new member of endogenous substrates for these effector caspases.
Results
Production of rev-caspase-7
Caspases are synthesized as inactive single-polypeptide zymogens and must be cleaved between the NH 2 -terminal of the large subunit (LS) and the COOH-terminal of the small subunit (SS) to be activated. Effector caspases, namely caspase-3, -6 and -7, cannot undergo autocatalytic processing and have an absolute requirement for`initiator' caspases such as caspase-8 and -9 for processing. 2 Srinivasula et al, based on the three-dimensional structure of active caspase-3, engineered contiguous caspase-3 and -6 molecules in which the SS was fused in-frame N-terminal to the LS, and a cleavage site (i.e., DEVDG in the case of caspase-3) was introduced between the two subunits 7 ( Figure 1A ). In contrast to their wild-type counterparts, these engineered rev-caspases, in which SS precedes LS, were able to undergo antocatalysis in an in vitro translation reaction and potently induced apoptosis when over expressed in cells, indicating that rev-caspase-3 and -6 spontaneously fold into active conformation.
Because caspase-3 and caspase-7 are highly related molecules, we constructed rev-caspase-7 along with caspase-3 using essentially the same strategy as Srinivasula and his coworkers ( Figure 1A ). First, we examined whether wild-type procaspases and rev-caspases undergo autocatalytic processing in an in vitro translation reaction ( Figure 1B ). As expected, rev-caspase-3 and -7 (Rev) were able to undergo processing into LS and SS in an in vitro system, whereas wild-type caspase-3 and -7 (WT) were not.
Moreover, the processing was completely inhibited by mutating the active site cysteine to serine of rev-caspase-3 and -7 (Rev-C/S), indicating that rev-caspase-3 and -7 are catalyzed by their own activities ( Figure 1B, lanes 3 and 6) .
Rev-caspase-7 retains activity in yeast
Given that rev-caspase-7-folded into active conformation in an in vitro translation system, we decided to clone molecules that interact with caspase-7, including substrates and inhibitors, using a yeast two-hybrid screening with revcaspase-7 as the bait. To determine whether rev-caspase-7 was also autoprocessed in yeast, we introduced cDNAs for wild-type procaspase-7, rev-caspase-7 and active site cysteine to serine mutant of rev-caspase-7 into the yeast two-hybrid vector pGilda. In this vector, cDNAs are expressed as NH 2 -terminal fusion proteins with the LexA DNA binding domain under control of the inducible GAL1 promoter. The expression of caspase-7 constructs was induced by incubation with galactose for 12 h and checked by Western blotting (Figure 2 ). Similar to the in vitro translation experiments, revcaspase-7 (Rev) was auto-processed to produce the large subunit (LS), whereas the active site mutant of rev-caspase-7 (Rev-C/S) was not. Interestingly, unlike the in vitro translation product, procaspase-7 (WT) was partially cleaved. This processing is most likely caused by autocatalysis induced by artificial massive expression of recombinant procaspase-7 in yeast. Moreover, expression of rev-caspase-7 in yeast, but not that of procaspase-7 or active site mutant of rev-caspase-7, impaired cell growth, consistent with the previous finding that caspase-3 expression induces growth inhibition in an activity-dependent manner 8 (data not shown).
Rev-caspase-7 and rev-caspase-7-C/S bind to natural caspase inhibitors in yeast
Baculovirus protein p35 and human inhibitor of apoptosis proteins (IAPs), XIAP, c-IAP1, c-IAP2 and survivin have been shown to tightly bind to and inhibit active caspase-7 but not inactive procaspase-7. 9 ± 12 Thus, we examined whether revcaspase-7 also bound to these natural caspase inhibitors in yeast to obtain evidence that rev-caspase-7 behaves similarly to active caspase-7. Yeasts were co-transformed with galactose-inducible pGilda-wild-type procaspase-7, -rev-caspase-7 or -rev-caspase-7-C/S and a galactose-inducible pJG4 Figure 3 , rev-caspase-7 bound to XIAP, but not to c-IAP1, c-IAP2, or p35, whereas wild-type procaspase-7 did not bind to XIAP, as expected. The growth of yeasts expressing rev-caspase-7 was generally inhibited, except for the one strain that expressed both rev-caspase-7 and XIAP (data not shown). On the other hand, rev-caspase-7-C/S bound to p35, in addition to XIAP. The growth of yeasts expressing rev-caspase-7-C/S was not impaired. These results indicate that rev-caspase-7 binds to at least some caspase inhibitors in yeasts. Neither rev-caspase-7 nor revcaspase-7-C/S mutant bound to c-IAP1, c-IAP2 or survivin, most likely because the binding affinities of these IAPs for caspase-7 are much lower than those of XIAP. 11, 13 Moreover, the inhibitory activity of p35 may not be strong enough to completely inhibit the activity of rev-caspase-7 in yeast, thus leading to growth arrest and a negative binding result. Based on these findings, we decided to use rev-caspase-7-C/S as bait in the screening of a yeast two-hybrid cDNA library in order to clone active caspase-7 interacting proteins, including substrates and inhibitors such as IAP or p35 related molecules.
Substrate candidates for caspase-7 were identified by yeast two-hybrid screening
We used pGilda-rev-caspase-7-C/S as a bait plasmid to screen a mouse adult brain cDNA library. A total of 110 positive clones were obtained by screening 2610 6 transformants. Partial sequencing of positive clones yielded 20 candidate molecules for caspase-7 interacting protein. To examine whether these clones were substrates for caspase-7, in vitro translates of these clones were produced and incubated with recombinant caspases. As shown in Figure  4A , four of the 20 candidates were cleaved by recombinant caspases, suggesting that these proteins were caspase substrates. Clone #15 was cleaved only by caspase-7, whereas clones #52, #77, and #105 were cleaved by both caspase-3 and -7 and also by caspase-6 to a lesser extent. Moreover, these four clones were cleaved by recombinant caspases in a dose dependent manner (data not shown). These results indicate that this system is highly effective in identifying caspase substrates.
PA28g was cleaved by caspase-3 and -7 in vitro
Of the substrate candidates, we focused on clone #105, which encoded mouse proteasome activator 28 subunit 3 (PA28g), as evolutionarily it is a very well conserved protein from drosophila to humans and appears to have a biologically important role. 14 First, we cloned full length human PA28g cDNA and confirmed that human PA28g was cleaved by recombinant caspase-3, -7 and also by caspase-6 to a lesser extent in vitro, consistent with partial clone (#105) cleavage ( Figure  4B and data not shown). These results suggest that the cleavage site for caspases is conserved between human and mouse. In the human PA28g sequence, we found a DGLD 80 G sequence, which was conserved in the corresponding sequence of mouse PA28g and very well fitted the optimal tetrapeptide recognition sequence for caspase-3 or -7 (DEXD). 15 To examine whether this sequence was Figure 2 Expression of rev-caspase-7 mutants in yeast. EGY48 yeast cells were transformed with pGilda expression plasmids carrying indicated caspase-7 mutants, and were grown overnight in SD-Trp, His, Ura liquid media containing 2% glucose. Cells were centrifuged and the cell pellet washed with sterile water. Cells were diluted to an OD 600 of 1.0 in 120 ml of fresh SD-Trp, His, Ura liquid media containing 2% galactose-1% raffinose to induce expression of caspase-7. After 12 h culture, total yeast lysates (50 mg/lane) were subjected to immunoblotting using anti-caspase-7 monoclonal antibody. 0.1 nM of purified recombinant caspase-7 was used as the positive control Figure 3 Binding assay of caspase-7-WT and rev-caspase-7 mutants to IAP family and p35 in yeast two-hybrid system. EGY48 yeast cells were transformed with pGilda plasmids carrying each caspase-7 mutant and pJG4-5 plasmids carrying various IAP family members (XIAP, c-IAP1, c-IAP2, or survivin) or baculovirus p35 or no insert (vector) and pSH18-34 plasmids carrying the lacZ reporter gene. Each of five transformants was spotted from selective glucose-containing medium onto selective gal/raf-inducing medium containing 80 mg/ml of X-gal Figure 4B and data not shown).
PA28g was cleaved by caspase-7 in vivo
To examine the cleavage of PA28g by caspase-7 in vivo, HEK 293T cells were co-transfected with HA-tagged caspase-7DN and caspase-7DN-C/S, of which the NH 2 -terminal 23 amino acids are deleted, and NH 2 -terminal Flagtagged PA28g. Unlike full-length procaspase-7, caspase-7DN was processed and induced cell death when overexpressed in mammalian cells (data not shown). As shown in Figure 5 , PA-WT was cleaved by caspase-7DN, generating an 11 kDa N-terminal fragment, but not by caspase-7DN-C/ S. The PA-EE mutant was not cleaved at all by caspase-7DN or caspase-7DN-C/S. Moreover, Flag-tagged PA28g was coimmunoprecipitated with the rev-caspase-7-C/S mutant after both plasmids were co-transfected into HEK293T cells, and the PA-EE mutant, unlike the wild type, hardly bound to revcaspase-7-C/S (data not shown). These data indicate that PA28g interacts with and is cleaved by caspase-7 at Asp-80 in vivo, in exactly the same way as in an in vitro cleavage experiment.
PA28g is an endogenous substrate of caspase-3/-7 like caspases
Next, we generated anti-serum against the C-terminal portion of PA28g (81 ± 92 a.a.), and checked the cleavage of endogenous PA28g during Fas-induced apoptosis of HeLa K cells. As shown in Figure 6 , PA28g was cleaved with a 35 S]-methionine. The translated products were incubated with recombinant caspases for 1 h, and then analyzed by SDS ± PAGE and autoradiography. (A) #15 was cleaved only by caspase-7 whereas #52, #77, #105 were cleaved not only by caspase-3 and -7 but also caspase-6 to a lesser extent. (B) Wildtype human PA28g DGLE 80 (PA ± WT) was cleaved by caspases, whereas PA28g mutants DGLE 80 (PA ± DE) and EGLE 80 (PA ± EE) were not. The Cterminal fragment of PA28g is denoted PA28g-C Figure 5 In vivo cleavage of PA28g by caspase-7DN in mammalian cells. 293T cells were co-transfected with HA-tagged caspase-7DN (in which the Nterminal 23 amino acids were deleted), and Flag-tagged PA28g. At 48 h after transfection, total cell lysates were prepared and then subjected to immunoblotting using anti-Flag monoclonal antibody and anti-caspase-7 polyclonal antibody. The N-terminal fragment of PA28g is denoted PA28g-N Figure 6 PA28g was cleaved during Fas-induced apoptosis by caspase-3/-7 like caspases. HeLa K cells were treated with anti-Fas monoclonal antibody at the indicated dose with or without 50 mM of z-DEVD-fmk or z-VAD-fmk. At 12 h after treatment, total cell lysates were prepared and then subjected to immunoblotting using anti-PA28g polyclonal antibody (1), anti-caspase-7 monoclonal antibody (2), anti-caspase-3 polyclonal antibody (3) and anti-PARP monoclonal antibody (4). PA28g was cleaved in a dose dependent manner accompanying caspase-7 and -3 activation, and the cleavage was blocked by caspase inhibitors
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PA28g is a substrate for caspase-3/-7 R Araya et al similar time course to that of the cleavage of caspase-7 or -3 during apoptosis. Moreover, the cleavage was blocked by zVAD-fmk, an irreversible pan-caspase peptide inhibitor, and zDEVD-fmk, an irreversible peptide inhibitor for caspase-3/-7 like caspases. Although the cleavage of caspase-3 was not inhibited by zDEVD-fmk treatment, caspase-3 activity was blocked, and therefore PARP, the substrates of caspase-3 and -7, was not cleaved at all. Like PARP, PA28g was not cleaved by caspase-3 and -7 upon zDEVD-fmk treatment. These findings indicate that PA28g is directly cleaved by caspase-7, -3, or closely related caspases in vivo.
Finally we examined whether endogenous PA28g is cleaved during the apoptosis of MCF-7 cells, which are devoid of caspase-3 owing to a functional deletion of the caspase-3 gene. 16 Despite the lack of caspase-3, this cell line shows sensitivity to various death stimuli, providing an excellent system with which to test whether caspase-3 is indispensable for the cleavage of a specific death substrate. 17 We induced apoptosis in MCF7 cells with addition of cisplatin and checked whether PA28g was cleaved in apoptotic MCF7 cells. Very similar to anti-Fas antibody-treated HeLa K cells, PA28g was cleaved with the concomitant processing of caspase-7, and the cleavage was inhibited by zVAD-fmk and zDEVD-fmk. These results indicate that endogenous PA28g in MCF7 cells is cleaved by a DEVD-specific caspase other than caspase-3, most likely caspase-7.
Discussion
The yeast two-hybrid system is a versatile method with which to systematically identify interacting proteins. In the present study, we used this system to clone caspase substrates using genetically engineered rev-caspase-7, and successfully identified PA28g as a substrate for caspase-3 or -7.
Previous to our study, Kamada et al developed a method of cloning the genes of caspase substrates using a modified yeast two-hybrid system, and identified gelsolin as a substrate of caspase-3. 18 They expressed large and small subunits separately using ADH1 promoter, which ensured an equimolar ratio of these two subunits. Compared to their method, our method of adopting an active site mutant of rev-caspase as bait enables utilization of any commercially available yeast two-hybrid vector and appears to be more convenient. On the other hand, unlike the Kamada et al method, in our procedure an active site mutant of rev-caspase-7 (rev-caspase-7-C/S) remains a single polypeptide due to the lack of autocatalysis, raising the possibility that this mutant does not have the proper structure of active caspase. We addressed this concern by demonstrating specific binding between rev-caspase-7-C/S and natural caspase inhibitors including p35 and XIAP. Recent structural studies have demonstrated that both inhibitors bind to the active site of caspase-7, indicating that rev-caspase-7-C/S retains a substrate binding groove identical to that of active caspase-7.
19 ± 22 Since revcaspase-3 and -6 have been engineered and shown to have the active form conformation, substrates for these caspases could also be systematically cloned using yeast two-hybrid screening with rev-caspases-C/S. 7 In the present study, we have identified PA28g as a substrate for caspase-3 or -7. PA28g was originally termed Ki antigen, which was initially identified using autoantibodies found in sera of patients with systemic lupus erythematosus. 23 Subsequent studies revealed that Ki antigen has sequence similarity to proteasome activators PA28a and PA28b, and was renamed PA28g. 24 PA28a and PA28b assemble into a heteromultimer called PA28, which has been shown to associate with and greatly stimulate multiple peptidase activities of the 20 S proteasome. PA28 is upregulated by stimulation with IFN-g and thought to be involved in the generation of MHC class I ligands. 25 In contrast, the physiological role of PA28g is unclear. Mice deficient in the PA28g gene are born without detectable developmental abnormalities. 26 However, mild growth retardation of PA28g 7/7 compared with PA28g +/7 or PA28g +/+ mice has been observed. Moreover, embryonic fibroblasts derived from PA28g 7/7 mice displayed a slower growth rate than those from wild-type mice, indicating that PA28g is involved in cell proliferation. Since PA28g localizes almost exclusively in the nucleus, it is speculated to play a role in the degradation of nuclear proteins regulating cell cycle progression. 26, 27 To examine the functional significance of the cleavage of PA28g during apoptosis, we observed the effect of over-expression of PA28gEE, a caspase-uncleavable mutant of PA28g, on apoptosis (refer to Figure 4) . However, over-expression of PA28gEE did not affect either the time course or cell morphology during apoptosis of HEK 293 cells and SH-SY5Y cells induced by various stimuli including Fas overexpression and tunicamycin treatment, respectively 12, 28 (data not shown). Further study is required to clarify the significance of caspase-3/-7-mediated cleavage of PA28g.
In conclusion, we have succeeded in identifying a novel substrate for caspase-3 or -7 using a yeast two-hybrid screening with rev-caspase-7 as bait. Systematic cloning of more caspase substrates using this convenient method will further elucidate the roles of caspases and their substrates in apoptosis. Figure 7 PA28g was cleaved during cisplatin induced apoptosis by a DEVDspecific caspase other than caspase-3. MCF7 cells were treated with 100 mM of cisplatin for the indicated time with or without 50 mM of zDEVD-fmk or zVADfmk. Total cell lysates were prepared and then subjected to immunoblotting using anti-PA28g polyclonal antibody (1) and anti-caspase-7 monoclonal antibody (2). PA28g was cleaved in a time dependent manner accompanying caspase-7 activation, and the cleavage was blocked by caspase inhibitors
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Material and Methods
Reagents, cell culture and transfection
Benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD-fmk) and benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone (zDEVDfmk) were purchased from Peptide Institute (Osaka, Japan) and Enzyme Systems Products (Livermore, CA, USA). HEK293T, HeLa K cells were kind gifts of Dr. S Yonehara and maintained in Dublecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum at 378C in humidified 5% CO 2 /95% air. HEK293T cells were transfected using Lipofectamine PLUS TM reagent (Gibco BRL, Grand Island, NY, USA) according to the manufacturer's instructions. MCF-7 cells were obtained from ATCC (Rockville, MD, USA) and maintained in DMEM supplement with 10% fetal bovine serum at 378C in humidified 5% CO 2 /95% air.
Construction of rev-caspase mutants
cDNAs encoding rev-caspase precursors were generated by PCR. Rev-caspase-3 was constructed as previously described. 7 To construct rev-caspase-7, the large and small subunits of caspase-7 were amplified with the following primers using the caspase-7 cDNA as a template: LS-forward, CCGGATCCATGGCA-GATGATCAGGGCTGTATT; LS-reverse, CTGCTCGAGTTAGTCGG-CCTGGATGCCATCATC; SS-forward, GGAATTCTCGGGGCCCAT-CAATGACACA; SS-reverse, CCGGATCCATCAACTTCATCTTGACT-GAAGTAGAGTTC. The LS PCR product was excised with BamHI/XhoI, while SS was excised with EcoRI/BamHI. These products were then simultaneously subcloned into the EcoRI/XhoI site of the mammalian expression vector pcDNA3 or that of the yeast expression vector pGilda.
Yeast transformation and characterization
The yeast strain EGY48 ((lexA operators) 6 -LEU2) was maintained on an appropriate dropout medium to select for plasmid marker expression. Transformations were performed using the LiOAc method using 1 mg of each plasmid (pGilda, pJG4-5, pSH18-34).
For cDNA library screening, EGY48 cells containing pGilda and pSH18-34 were grown in glucose containing synthetic dropout liquid medium lacking histidine and uracil (SD-His, Ura). The cells were then transformed with 125 mg of mouse adult brain cDNA library using the LiOAc method. Transformants were plated onto galactose/raffinose, Xgal-containing SD-Trp, His, Ura plates which lacks tryptophan in addition to histidine and uracil. An aliquot of transformants was also plated onto glucose-containing SD-Trp, His, Ura plates to determine transformation efficiency. The blue colonies on galactose/raffinose, Xgal-containing SD-Trp, His, Ura plates were spotted onto galactose/ raffinose, X-gal -containing SD-Trp, His, Ura, Leu plates.
In vitro translation of caspases or positive yeast two-hybrid clones
Caspases and yeast two-hybrid clones were in vitro translated in the presence of [
35 S]methionine in rabbit reticulocyte lysate with a T7-RNA polymerase-coupled TNT kit (Promega, Madison, WI, USA), using the pcDNA3 constructs as templates according to the manufacturer's instructions.
Generation of anti-PA28g polyclonal antibody
Antibodies were raised against a region of human PA28g protein spanning amino acids 81 ± 92, which are located immediately after the putative caspase-3/-7 cleavage site DGLD. A synthetic polypeptide (GPTYKKRRLDEC) was cross-linked to keyhole limpet hemocyanine (KLH, Pierce, Rockford, IL, USA), emulsified in Freund's adjuvant, and used to immunize rabbits (1 mg in complete Freund's adjuvant for the first injection, followed every 2 ± 3 weeks by 1 mg in incomplete Freund's adjuvant). Rabbit serum were divided into aliquots and kept frozen at 7208C.
Immunoblot analyses
The yeast cell cultures were centrifuged at 50006g and the cell pellet washed with sterile water and resuspended in lysis buffer (20 mM PIPES pH 7.2, 100 mM NaCl, 1 mM EDTA, 10% Sucrose, 0.1% CHAPS, 10 mM DTT). Equal volumes of acid-washed 0.6 mm glass beads were added to each sample followed by vortexing for 10630 s with 1 min intervals on ice. Equal amounts of each sample (50 mg protein) were subjected to 16% SDS ± PAGE followed by transfer to a PVDF membrane. The membrane was probed with anti-caspase-7 monoclonal antibody (MBL, Nagoya, Japan).
The mammalian cells (5610 5 ) were washed with PBS and resuspended in lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA) with a protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany). Equal amounts of each sample (30 mg protein) were subjected to 16% SDS ± PAGE followed by transfer to a PVDF membrane. The membrane was probed with anti-PA28g polyclonal antibody, anti-Flag monoclonal antibody (Sigma, St. Louis, MO, USA), anti-caspase-7 monoclonal antibody (MBL), anti-caspase-3 polyclonal antibody (a gift from Dr. Hong-Gang Wang) and anti-PARP monoclonal antibody (Clontech, Palo Alto, CA, USA).
